Eli Casdin - Jul 22, 2021 Form 4 Insider Report for Sema4 Holdings Corp. (WGSWW)

Role
Director
Signature
/s/ Eli Casdin
Stock symbol
WGSWW
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
4
Date filed
7/27/2021, 06:09 AM
Previous filing
Jul 21, 2021
Next filing
Jul 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGSWW Class A Common Stock Conversion of derivative security $0 +11M $0.00 11M Jul 22, 2021 By CMLS Holdings LLC F1, F2
transaction WGSWW Class A Common Stock Award $0 +5M $0.00 5M Jul 22, 2021 Casdin Partners Master Fund, LP F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGSWW Warrants to purchase Class A Common Stock (right to buy) Award +6.74M 6.74M Jul 22, 2021 Class A Common Stock 6.74M $11.50 By CMLS Holdings LLC F1, F2, F4
transaction WGSWW Class B Common Stock Conversion of derivative security $0 -11M -100% $0.00* 0 Jul 22, 2021 Class A Common Stock 11M By CMLS Holdings LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences, Inc. or "CMLS") and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), among other things, each share of CMLS's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis.
F2 The securities are held of record by CMLS Holdings LLC ("CMLS Holdings"). CMLS Holdings LLC is the record holder of the Class A common stock and the Class A Common Stock exercisable upon the issuance of warrants reported herein. The Board of Managers of CMLS Holdings LLC is comprised of Mr. Casdin and Mr. Keith Meister who share voting and investment discretion with respect to the Class A common stock held of record by CMLS Holdings LLC. C-LSH LLC and M-LSH LLC are the members of CMLS Holdings LLC, and Messrs. Casdin and Meister are the managing members of C-LSH LLC and M-LSH LLC, respectively. As such, Mr. Casdin may be deemed to have or share beneficial ownership of the securities held directly by CMLS Holdings LLC. Each of C-LSH LLC and Mr. Casdin disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.
F3 The securities reflected as beneficially owned by Casdin Partners Master Fund, LP in the table above consists of 5,000,000 shares of Class A common stock. Such securities are owned directly by Casdin Partners Master Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, LP, (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Mr. Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Mr. Casdin disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein.
F4 Following the completion of the business combination, warrants to purchase Class A Common Stock become exercisable on September 5, 2021, the date that is one year after the closing of the IPO of Sema4's predecessor, CMLS.